BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8666924)

  • 1. Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression.
    Mohapatra S; Yang X; Wright JA; Turley EA; Greenberg AH
    J Exp Med; 1996 Apr; 183(4):1663-8. PubMed ID: 8666924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.
    Matou-Nasri S; Gaffney J; Kumar S; Slevin M
    Int J Oncol; 2009 Oct; 35(4):761-73. PubMed ID: 19724912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krüppel-like factor 5 promotes mitosis by activating the cyclin B1/Cdc2 complex during oncogenic Ras-mediated transformation.
    Nandan MO; Chanchevalap S; Dalton WB; Yang VW
    FEBS Lett; 2005 Aug; 579(21):4757-62. PubMed ID: 16102754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage.
    Jin P; Hardy S; Morgan DO
    J Cell Biol; 1998 May; 141(4):875-85. PubMed ID: 9585407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.
    Vincent I; Jicha G; Rosado M; Dickson DW
    J Neurosci; 1997 May; 17(10):3588-98. PubMed ID: 9133382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RHAMM/hyaluronan inhibit β-catenin degradation, enhance downstream signaling, and facilitate fibrosarcoma cell growth.
    Berdiaki A; Thrapsanioti LN; Giatagana EM; K Karamanos N; C Savani R; N Tzanakakis G; Nikitovic D
    Mol Biol Rep; 2023 Nov; 50(11):8937-8947. PubMed ID: 37710072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
    Park M; Chae HD; Yun J; Jung M; Kim YS; Kim SH; Han MH; Shin DY
    Cancer Res; 2000 Feb; 60(3):542-5. PubMed ID: 10676633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses.
    Kawamoto H; Koizumi H; Uchikoshi T
    Am J Pathol; 1997 Jan; 150(1):15-23. PubMed ID: 9006317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient suppression of nuclear Cdc2 activity in response to ionizing radiation.
    Kim MJ; Lee JY; Lee SJ
    Oncol Rep; 2008 May; 19(5):1323-9. PubMed ID: 18425394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immortal, non-tumourigenic mouse mammary outgrowths express high levels of cyclin B1 and activation of cyclin B1/cdc2 kinase.
    Said TK; Bonnette S; Medina D
    Cell Prolif; 1996 Nov; 29(11):623-39. PubMed ID: 9105418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Receptor for Hyaluronan-Mediated Motility (CD168) promotes inflammation and fibrosis after acute lung injury.
    Cui Z; Liao J; Cheong N; Longoria C; Cao G; DeLisser HM; Savani RC
    Matrix Biol; 2019 May; 78-79():255-271. PubMed ID: 30098420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geldanamycin induces G2 arrest in U87MG glioblastoma cells through downregulation of Cdc2 and cyclin B1.
    Nomura N; Nomura M; Newcomb EW; Zagzag D
    Biochem Pharmacol; 2007 May; 73(10):1528-36. PubMed ID: 17324379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events.
    De Souza CP; Ellem KA; Gabrielli BG
    Exp Cell Res; 2000 May; 257(1):11-21. PubMed ID: 10854050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein A-stimulated macrophage chemotaxis.
    Foley JP; Lam D; Jiang H; Liao J; Cheong N; McDevitt TM; Zaman A; Wright JR; Savani RC
    J Biol Chem; 2012 Oct; 287(44):37406-19. PubMed ID: 22948158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
    Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
    PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of receptor for hyaluronan-mediated motility (RHAMM) in MC3T3-E1 cells induces proliferation and differentiation through phosphorylation of ERK1/2.
    Hatano H; Shigeishi H; Kudo Y; Higashikawa K; Tobiume K; Takata T; Kamata N
    J Bone Miner Metab; 2012 May; 30(3):293-303. PubMed ID: 21947782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
    Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
    Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid, CD44 and RHAMM regulate myoblast behavior during embryogenesis.
    Leng Y; Abdullah A; Wendt MK; Calve S
    Matrix Biol; 2019 May; 78-79():236-254. PubMed ID: 30130585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 regulates a G2 checkpoint through cyclin B1.
    Innocente SA; Abrahamson JL; Cogswell JP; Lee JM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2147-52. PubMed ID: 10051609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells.
    Jin P; Gu Y; Morgan DO
    J Cell Biol; 1996 Aug; 134(4):963-70. PubMed ID: 8769420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.